mart-1-antigen has been researched along with Vulvar-Neoplasms* in 4 studies
1 review(s) available for mart-1-antigen and Vulvar-Neoplasms
Article | Year |
---|---|
Amelanotic vulvar melanoma: case report and review of the literature.
A rare case of amelanotic vulvar melanoma is presented. The patient was a 71-year-old woman complaining of vulvar itching and yellowish vaginal discharge who underwent a complete gynecological evaluation during which a suspicious grey-whitish mass on her vulva was observed. The tumor presented superficial ulceration and was located in the upper half of the labia minora and clitoris. Initially it was suspected to be a vulvar carcinoma. A biopsy was taken and a histopathological suspicion of amelanotic melanoma was rendered. The mass was radically excised and the diagnosis was confirmed using HMB-45, Melan-A and anti-S-100 protein antibodies. Malignant melanoma is readily diagnosed by the presence of melanin granules. Although amelanotic melanoma contains a few melanin granules, it is often difficult to differentiate it from other non-epithelial malignant tumors. This report describes a case of amelanotic melanoma of the vulva, which was correctly diagnosed by immunohistochemical staining with the HMB-45, Melan-A antibody and for the S-100 protein. Topics: Aged; Antigens, Neoplasm; Female; Humans; MART-1 Antigen; Melanoma-Specific Antigens; Melanoma, Amelanotic; Neoplasm Proteins; S100 Proteins; Vulvar Neoplasms | 2008 |
3 other study(ies) available for mart-1-antigen and Vulvar-Neoplasms
Article | Year |
---|---|
Evaluation of large clinically atypical vulvar pigmentation with RCM: atypical melanosis or early melanoma?
Vulvar melanosis can occasionally be clinically challenging by mimicking an early melanoma.. To report our experience of initial evaluation and follow-up in this peculiar subset of vulvar melanosis using reflectance confocal microscopy (RCM).. We retrospectively evaluated 18 consecutive cases referred for atypical vulvar pigmentation or for which melanoma was considered and that underwent both RCM examination and histopathological assessment. In 13 cases with available dermoscopic pictures, RCM classification was compared to dermoscopic diagnosis, and in all cases, the density of melanocytes was evaluated on biopsies using MelanA immunostaining.. Among the 18 atypical pigmented lesions, 17 vulvar melanosis and one melanoma were histologically determined. RCM concluded a benign vulvar melanosis in 10 of 17 cases, whereas dermoscopy did so in three of 12 cases. RCM identified the only early malignant lentiginous melanoma. In several cases of vulvar melanosis, RCM could identify foci of melanocytic hyperplasia in an otherwise benign pattern.. In this clinically and dermoscopically challenging subset of vulvar pigmentations, RCM appears relevant for initial extensive evaluation, especially to target initial biopsy sampling, and to perform non-invasive monitoring of foci of melanocytic hyperplasia. Topics: Adult; Aged; Aged, 80 and over; Biopsy; Dermoscopy; Diagnosis, Differential; Female; Humans; MART-1 Antigen; Melanoma; Melanosis; Microscopy, Confocal; Middle Aged; Retrospective Studies; Skin; Vulvar Neoplasms | 2019 |
Amelanotic vulvar melanoma with intratumor histological heterogeneity.
Amelanotic vulvar melanoma is a rare type of malignant melanoma. This paper describes a case of an asymptomatic ulcerated nodule 20 mm in size. The tumor cells from the nodular lesion showed positive staining immunohistochemically for Melan-A, but negative staining with HMB-45. The cells showed negative reactivity to S-100 except in one region. The melanoma cells in the epidermis were detected in one of the specimens from the excised tumor nodule. The cells in the epidermis showed positive staining for Melan-A and S-100 and partial staining with HMB-45. The tumor was diagnosed as malignant melanoma of the vulva and immunohistochemically shown to have intratumor histological heterogeneity. This case suggests the importance of viewing non-pigmented nodules on the vulva of elderly females as potentially malignant melanoma, and that a combination of immunohistochemical stains may be useful for recognizing the stage of the melanosomes in the melanoma cells. Topics: Aged, 80 and over; Antigens, Neoplasm; Female; Humans; Immunohistochemistry; MART-1 Antigen; Melanoma, Amelanotic; Neoplasm Proteins; Vulva; Vulvar Neoplasms | 2010 |
Vulvar malignant melanoma following radiotherapy for cervical cancer.
Topics: Antigens, Neoplasm; Female; Humans; MART-1 Antigen; Melanoma; Neoplasm Proteins; Neoplasms, Squamous Cell; Radiotherapy; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2002 |